Serum high sensitivity C reactive protein and lipid profile in obese students

Sangeeta B. Trimbake, Shilpa A. Pratinidhi, Yash K. Majithia


Background: The prevalence of overweight and obesity is progressively increasing in younger and adult population in India. It is a medical problem that increases risk of other diseases and health problems, such as heart disease, diabetes, high blood pressure and certain cancers. One of the causes of dyslipidaemia is obesity. High sensitivity C-Reactive Protein (hs-CRP), is a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease. Hence it is important to check the relationship of hs-CRP with lipid profiles in obese and non-obese students.

Methods: A case control observational study was carried out in 60 students. They were divided in to two groups obese and non-obese based on the BMI ranges. Serum lipid levels, hs-CRP and BMI was estimated in both groups to find out correlation of hs-CRP with lipid profile and BMI.

Results: There was a significant rise in serum Total Cholesterol, LDL-C, Triacylglycerol and a significant fall in HDL-C in obese group as compared to non-obese group. Serum hs-CRP and BMI was significantly increased in obese students as compared to non-obese students. There was statistically significant positive correlation found between hs-CRP and total cholesterol, LDL-C, Triacylglycerol in obese students.

Conclusions: Significant correlation was found between hs-CRP and lipid profile except HDL-C. Serum hs-CRP levels may decrease by treatment of dyslipidaemia. This would minimize the incidence of atherosclerosis and hence decrease the risk for development of coronary artery disease. Hence, improving the quality of life.


High density lipoprotein-cholesterol, High sensitivity C-reactive protein, Low density lipoprotein-cholesterol, Obesity, Total cholesterol, Triacylglycerol

Full Text:



WHO Committee. Geneva, World Health Organisation. Technical report series: Physical Status: The use and interpretation of anthropometry, 1995.Available at http;//apps, Accessed 8 November 1995.

World Health Organisation. Technical report series: Obesity: preventing and managing the global epidemic, 2000. Available at http;//apps, Accessed 5 June 2000.

Haslam DW, James WP. Obesity. Lancet. 2005;366:1197-209.

Yudkin JS, Stehouwer C, Emeis J, Coppack S. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arteriosclerosis, Thromb Vascular Biol. 1999 Apr;19(4):972-8.

Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab. 1997 Dec 1;82(12):4196-200.

Ridker PM. Novel risk factors and markers for coronary disease. Advan Int Med. 2000;45:391.

Myers GL, Kimberly MM, Waymack PP, Smith SJ, Cooper GR, Sampson EJ. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem. 2000 Nov 1;46(11):1762-72.

Henry J. Guide to clinical laboratory diagnosis. In: McPherson R, Pincus M eds. Clinical diagnosis and management of laboratory methods. 23rd ed. W.B. Saunders Philadelphia; 2011: 204-211.

Miller WG, Myers GL, Sakurabayashi I, Bachman LM, Laudill SP, Dzerekonski A, et al. Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures. Clin Chem. 2010;56(6):977-86.

Denka S. Evaluation of turbidometric C-Reactive proetein assay for cardiovascular risk estimation and conventional inflammation diagnosis. Clin Chem. 2003:49;511-12.

Klisic A, Vasiljevic N, Simic T, Djukic T, Maksimovic M, Matic M. Association between C - reactive protein, anthropometric and lipid parameters, among healthy normal weight and overweight postmenopausal women in Montenegro. Lab Med. 2014;45(1):12-16.

Kao TW, Lu IS, Liao KC, Lai HY, Loh CH, Kuo HK. Associations between body mass index and serum levels of C-reactive protein. South African Med J. 2009;99(5).

Lin CC, Kardia SL, Li CI, Liu CS, Lai MM, Lin WY, et al. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Pub Health. 2010 Dec;10(1):579.

Kalra S, Unnikrishnan AG. Obesity in India: The weight of the nation. J Med Nutr Nutraceu. 2012 Jan 1;1(1):37.

Stępień M, Stępień A, Wlazeł RN, Paradowski M, Banach M, Rysz J. Obesity indices and inflammatory markers in obese non-diabetic normo-and hypertensive patients: a comparative pilot study. Lipids Health Dis. 2014 Dec;13(1):29.

Mahmoud E, Ali Rea Heidari-Bakavoli, Sara S, Seyed R, Mirhafez, Mohsen M, Habibollah E, et al. Association of serum hs-CRP levels with presence of obesity, Diabetes Mellitus and other cardiovascular risk factors. J Clin Lab Analysis. 2016;5:1-12.

Sudha V, UK Abdul R, Prashanth CK, Muralidhar DV, Bairy KL. Highly Sensitive C-reactive protein in metabolic syndrome. JIACM. 2013;14(3-4):230-34.

Hana T, Abdulnabi TA, Ali A, Thaier AA, Obeid A, AlMutari, et al. Prevalence of dyslipidaemia and obesity among the college students in Kuwait. Alexandria J Med. 2011;1:67-71.

Lavanya K, Ramamoorthi K, Acharya RV, Madhyastha SP. Association between Overweight, Obesity in Relation to Serum Hs-CRP Levels in Adults 20-70 Years. J Clin Diag Res. 2017 Dec 1;11(12).

Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab. 2001 Mar 1;86(3):1154-9.

Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin‐6 in relation to adiposity, insulin action, and insulin secretion. Obesity Res. 2001 Jul;9(7):414-7.